About Vivus
Vivus is a company based in Mountain View (United States) founded in 1991. The company has 59 employees as of February 29, 2020. Vivus offers products and services including PANCREAZE and QSYMIA. Vivus operates in a competitive market with competitors including Actelion, Adocia, Altimmune, Carmot and BioAge Labs, among others.
- Headquarter Mountain View, United States
- Employees 59 as on 29 Feb, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vivus Llc
-
Annual Revenue
$69.76 M (USD)7as on Dec 31, 2019
-
Net Profit
-$31.5 M (USD)15as on Dec 31, 2019
-
EBITDA
-$10.97 M (USD)-215as on Dec 31, 2019
-
Latest Funding Round
$253 M (USD), Post-IPO
May 01, 2013
- Investors
-
Employee Count
59
as on Feb 29, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivus
Vivus offers a comprehensive portfolio of products and services, including PANCREAZE and QSYMIA.
Manages Exocrine Pancreatic Insufficiency to reduce diarrhea and malnutrition.
Supports weight management through clinical treatment for obesity.
People of Vivus
Unlock access to complete
Sales and Marketing
17 people
Leadership Team
6 people
Software Development Team
4 people
Human Resources and Administration
2 people
Data Analysis and Operations Team
2 people
Legal and Compliance
2 people
Product Management Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Vivus
Investors in Vivus
Vivus has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Locked | Locked | Locked |
Investor details for Vivus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vivus
Investment portfolio details for Vivus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vivus
Detailed financials for Vivus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivus Comparisons
Peer comparison for Vivus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vivus
Vivus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Actelion, Adocia, Altimmune, Carmot and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Innovative treatments for orphan diseases are discovered, developed, and commercialized.
|
|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| Locked | Locked | Locked |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
Detailed competitors of Vivus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivus
Complete news archive for Vivus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivus
Vivus was founded in 1991 and raised its 1st funding round 2 years after it was founded.
Vivus is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
As of Feb 29, 2020, the latest employee count at Vivus is 59.
Annual revenue of Vivus is $69.76M as on Dec 31, 2019.
Vivus was established in 1991 in Mountain View, United States, within the pharmaceutical sector. Drug development and commercialization efforts are centered on treatments for obesity and sexual health conditions. A pipeline program featuring Tacrolimus is directed toward pulmonary arterial hypertension management. Operations encompass research, clinical trials, and market introduction of these therapies across the United States.
Vivus's top competitors include Adocia, BioAge Labs and Fractyl.
Vivus offers PANCREAZE and QSYMIA.
Vivus has 1 investor. Key investors include Frazier Healthcare Partners.